AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy-Reference-Cited by-同舟云学术

AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy

Published:2014-03 Issue:3 Volume:22 Page:511-521
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sahenk Zarife,Galloway Gloria,Clark Kelly Reed,Malik Vinod,Rodino-Klapac Louise R,Kaspar Brian K.,Chen Lei,Braganza Cilwyn,Montgomery Chrystal,Mendell Jerry R

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Genetic and clinical aspects of Charcot-Marie-Tooth's disease;Skre;Clin Genet,1974

2. 17p duplicated Charcot-Marie-Tooth 1A: characteristics of a new population;Marques;J Neurol,2005

3. Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease;Houlden;Neuromolecular Med,2006

4. DNA duplication associated with Charcot-Marie-Tooth disease type 1A;Lupski;Cell,1991

5. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group;Raeymaekers;Neuromuscul Disord,1991

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease;Pharmaceuticals;2024-07-28

2. Delivery of neurotrophin-3 by RVG-Lamp2b-modified mesenchymal stem cell-derived exosomes alleviates facial nerve injury;Human Cell;2024-06-11

3. The Impacts of Intervertebral Disc Degeneration of the Spine, Alcohol Consumption, Smoking Tobacco Products, and Glycemic Disorders on the Expression Profiles of Neurotrophins-3 and -4;Biomedicines;2024-02-13

4. Targeting muscle to treat Charcot-Marie-Tooth disease;Neural Regeneration Research;2023-12-11

5. AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells;Communications Medicine;2023-11-28